Celladon Corporation (CLDN) was a big mover last session, as its shares rose almost 10% on the day. This led to more shares changing hands than in a normal session. Yesterday’s rally reverses the downtrend for the company, as the stock is now up down over 29% in the past one-month time frame.
Over the last 7 days, the company did not witness any estimate revision while the Zacks Consensus Estimate moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
Celladon currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
A better-ranked biomedical stock is Affymetrix Inc. (AFFX) with a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment